Dr. Frederick (Fritz) C. Eilber
Dr. Eilber was specifically recruited back to the Division of Surgical Oncology at UCLA to take over the leadership of the UCLA Sarcoma Program, with the goal of developing a translational research program to compliment its clinical prominence. This program has become the UCLA Sarcoma Clinical / Translational Research Program within the Jonnson Comprehensive Cancer Center (JCCC) and a Program Area in the Institute of Molecular Medicine. Dr. Eilber is director of both of these Sarcoma Program Areas. Dr. Eilber’s sarcoma research is focused on translating molecular oncology from the laboratory to the clinic in a rapid and clinically relevant manner with the goal of swiftly impacting patient care. His long-term objective is to rationally apply molecularly targeted therapies in the context of defined genetic lesions thus developing effective and individualized therapeutic strategies for patients with sarcoma. His efforts have recently focused on applying molecular imaging to evaluate response to systemic therapy (traditional chemotherapy, targeted therapy) and direct regional therapies (surgery, radiation therapy, embolization) in sarcoma. |